<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Pathology News | Tissuepathology.com</title>
	<atom:link href="https://tissuepathology.com/category/posts/feed/" rel="self" type="application/rss+xml" />
	<link>https://tissuepathology.com</link>
	<description>Educational and informative</description>
	<lastBuildDate>Wed, 30 Sep 2026 12:10:25 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	

<image>
	<url>https://tissuepathology.com/wp-content/uploads/2017/07/cropped-Portrait_640x960px-32x32.png</url>
	<title>Pathology News | Tissuepathology.com</title>
	<link>https://tissuepathology.com</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>ViewsML Appoints Digital Pathology Executive Michael Rivers to Board of Directors</title>
		<link>https://tissuepathology.com/2026/09/30/viewsml-appoints-digital-pathology-executive-michael-rivers-to-board-of-directors/</link>
		
		<dc:creator><![CDATA[Erica Goodpaster]]></dc:creator>
		<pubDate>Wed, 30 Sep 2026 12:10:25 +0000</pubDate>
				<category><![CDATA[Business]]></category>
		<category><![CDATA[Digital Pathology News]]></category>
		<category><![CDATA[Pathology News]]></category>
		<category><![CDATA[Press Release]]></category>
		<category><![CDATA[Board of Directors]]></category>
		<category><![CDATA[Michael Rivers]]></category>
		<category><![CDATA[ViewsML]]></category>
		<guid isPermaLink="false">https://tissuepathology.com/?p=24709</guid>

					<description><![CDATA[<p>Rivers brings more than 20 years of experience commercializing diagnostic and digital pathology technologies to support ViewsML’s continued growth and innovation Vancouver, BC —September 29, 2026— ViewsML, a leader in AI-powered virtual biomarker staining, today announced the appointment of Michael Rivers to its Board of Directors. Rivers brings more than 20 years of experience leading [&#8230;]</p>
The post <a href="https://tissuepathology.com/2026/09/30/viewsml-appoints-digital-pathology-executive-michael-rivers-to-board-of-directors/">ViewsML Appoints Digital Pathology Executive Michael Rivers to Board of Directors</a> first appeared on <a href="https://tissuepathology.com">Tissuepathology.com</a>.]]></description>
		
		
		
			</item>
		<item>
		<title>Proscia: How Unilabs is Advancing Digital Pathology and Precision Medicine with Proscia</title>
		<link>https://tissuepathology.com/2026/09/25/proscia-how-unilabs-is-advancing-digital-pathology-and-precision-medicine-with-proscia/</link>
		
		<dc:creator><![CDATA[Erica Goodpaster]]></dc:creator>
		<pubDate>Fri, 25 Sep 2026 15:11:45 +0000</pubDate>
				<category><![CDATA[Artificial Intelligence]]></category>
		<category><![CDATA[Blogs]]></category>
		<category><![CDATA[Digital Pathology News]]></category>
		<category><![CDATA[Health Technology Collaboration]]></category>
		<category><![CDATA[Pathology News]]></category>
		<category><![CDATA[AI]]></category>
		<category><![CDATA[digital pathology]]></category>
		<category><![CDATA[image analysis]]></category>
		<category><![CDATA[Pathology]]></category>
		<category><![CDATA[Precision Medicine]]></category>
		<category><![CDATA[Proscia]]></category>
		<category><![CDATA[Unilabs]]></category>
		<guid isPermaLink="false">https://tissuepathology.com/?p=24702</guid>

					<description><![CDATA[<p>From the Proscia blog: Every patient’s care journey starts with a diagnosis. As our understanding of disease becomes more nuanced, pathologists are expected to deliver increasingly specific answers. Meanwhile, their expertise is in short supply, and demand for diagnostic services continues to rise. Many laboratories are finding it harder to consistently provide the timely, informed [&#8230;]</p>
The post <a href="https://tissuepathology.com/2026/09/25/proscia-how-unilabs-is-advancing-digital-pathology-and-precision-medicine-with-proscia/">Proscia: How Unilabs is Advancing Digital Pathology and Precision Medicine with Proscia</a> first appeared on <a href="https://tissuepathology.com">Tissuepathology.com</a>.]]></description>
		
		
		
			</item>
		<item>
		<title>Grundium Announces New Chapter</title>
		<link>https://tissuepathology.com/2026/09/24/grundium-announces-new-chapter/</link>
		
		<dc:creator><![CDATA[Erica Goodpaster]]></dc:creator>
		<pubDate>Thu, 24 Sep 2026 11:34:39 +0000</pubDate>
				<category><![CDATA[Artificial Intelligence]]></category>
		<category><![CDATA[Digital Pathology News]]></category>
		<category><![CDATA[Pathology News]]></category>
		<category><![CDATA[AI]]></category>
		<category><![CDATA[digital pathology]]></category>
		<category><![CDATA[Grundium]]></category>
		<category><![CDATA[image analysis]]></category>
		<category><![CDATA[LinkedIn]]></category>
		<category><![CDATA[Pathology]]></category>
		<guid isPermaLink="false">https://tissuepathology.com/?p=24700</guid>

					<description><![CDATA[<p>From Grundium on LinkedIn: Meet Grundium Ocus® R. A new member of the Ocus family. A new chapter for Grundium. We’re bringing our commitment to image quality, compact design and effortless use into high-throughput digital pathology. Up to 12 independent scanning heads. One compact robotic platform. Load-and-go automation that keeps your workflow moving. Discover Ocus [&#8230;]</p>
The post <a href="https://tissuepathology.com/2026/09/24/grundium-announces-new-chapter/">Grundium Announces New Chapter</a> first appeared on <a href="https://tissuepathology.com">Tissuepathology.com</a>.]]></description>
		
		
		
			</item>
		<item>
		<title>Deciphex launches CipherX: a step beyond foundation models, an AI engine for any pathology question</title>
		<link>https://tissuepathology.com/2026/09/22/deciphex-launches-cipherx-a-step-beyond-foundation-models-an-ai-engine-for-any-pathology-question/</link>
		
		<dc:creator><![CDATA[Erica Goodpaster]]></dc:creator>
		<pubDate>Tue, 22 Sep 2026 10:42:18 +0000</pubDate>
				<category><![CDATA[Artificial Intelligence]]></category>
		<category><![CDATA[Clinical Laboratories]]></category>
		<category><![CDATA[Digital Pathology News]]></category>
		<category><![CDATA[Image Analysis]]></category>
		<category><![CDATA[International]]></category>
		<category><![CDATA[Pathology News]]></category>
		<category><![CDATA[AI]]></category>
		<category><![CDATA[CipherX]]></category>
		<category><![CDATA[Computational Pathology]]></category>
		<category><![CDATA[Deciphex]]></category>
		<category><![CDATA[Diagnexia]]></category>
		<category><![CDATA[digital pathology]]></category>
		<category><![CDATA[Foundation Model]]></category>
		<category><![CDATA[image analysis]]></category>
		<category><![CDATA[Pathology]]></category>
		<category><![CDATA[Patholytix]]></category>
		<guid isPermaLink="false">https://tissuepathology.com/?p=24692</guid>

					<description><![CDATA[<p>Deciphex today introduces CipherX, the AI engine behind its clinical diagnostic service, Diagnexia, and its pharmaceutical research business, Patholytix. CipherX has been in production since January 2026 and is launched publicly for the first time today.‍ A pathology foundation model is a large neural network trained on millions of tissue images to convert each image [&#8230;]</p>
The post <a href="https://tissuepathology.com/2026/09/22/deciphex-launches-cipherx-a-step-beyond-foundation-models-an-ai-engine-for-any-pathology-question/">Deciphex launches CipherX: a step beyond foundation models, an AI engine for any pathology question</a> first appeared on <a href="https://tissuepathology.com">Tissuepathology.com</a>.]]></description>
		
		
		
			</item>
		<item>
		<title>Leica Biosystems Advances Histology Workflow Efficiency and Traceability with New High-Speed Laser Cassette Printer</title>
		<link>https://tissuepathology.com/2026/09/21/leica-biosystems-advances-histology-workflow-efficiency-and-traceability-with-new-high-speed-laser-cassette-printer/</link>
		
		<dc:creator><![CDATA[Erica Goodpaster]]></dc:creator>
		<pubDate>Mon, 21 Sep 2026 12:51:43 +0000</pubDate>
				<category><![CDATA[Anatomic Pathology]]></category>
		<category><![CDATA[Artificial Intelligence]]></category>
		<category><![CDATA[Digital Pathology News]]></category>
		<category><![CDATA[Laboratory Management & Operations]]></category>
		<category><![CDATA[Pathology News]]></category>
		<category><![CDATA[Press Release]]></category>
		<category><![CDATA[AI]]></category>
		<category><![CDATA[digital pathology]]></category>
		<category><![CDATA[histology]]></category>
		<category><![CDATA[image analysis]]></category>
		<category><![CDATA[laser cassette printer]]></category>
		<category><![CDATA[leica biosystems]]></category>
		<category><![CDATA[Pathology]]></category>
		<category><![CDATA[workflow]]></category>
		<guid isPermaLink="false">https://tissuepathology.com/?p=24689</guid>

					<description><![CDATA[<p>Leica Biosystems: HistoCore LIGHTNING C Laser Cassette Printer helps laboratories improve specimen identification and tracking while reducing costs DEER PARK, Ill., SEPTEMBER 16, 2026 – Leica Biosystems, a Danaher company and a global leader in end-to-end anatomic and digital pathology solutions, reinforces its commitment to connected pathology workflow efficiency with the global launch of the HistoCore LIGHTNING [&#8230;]</p>
The post <a href="https://tissuepathology.com/2026/09/21/leica-biosystems-advances-histology-workflow-efficiency-and-traceability-with-new-high-speed-laser-cassette-printer/">Leica Biosystems Advances Histology Workflow Efficiency and Traceability with New High-Speed Laser Cassette Printer</a> first appeared on <a href="https://tissuepathology.com">Tissuepathology.com</a>.]]></description>
		
		
		
			</item>
		<item>
		<title>Proscia: Freedom to Grow: Why an Open, Interoperable Platform Is Non-Negotiable for Digital Pathology</title>
		<link>https://tissuepathology.com/2026/09/18/proscia-freedom-to-grow-why-an-open-interoperable-platform-is-non-negotiable-for-digital-pathology/</link>
		
		<dc:creator><![CDATA[Erica Goodpaster]]></dc:creator>
		<pubDate>Fri, 18 Sep 2026 13:50:28 +0000</pubDate>
				<category><![CDATA[Artificial Intelligence]]></category>
		<category><![CDATA[Blogs]]></category>
		<category><![CDATA[Digital Pathology News]]></category>
		<category><![CDATA[Image Analysis]]></category>
		<category><![CDATA[Pathology News]]></category>
		<category><![CDATA[AI]]></category>
		<category><![CDATA[Blog]]></category>
		<category><![CDATA[digital pathology]]></category>
		<category><![CDATA[image analysis]]></category>
		<category><![CDATA[Interoperability]]></category>
		<category><![CDATA[Pathology]]></category>
		<category><![CDATA[Proscia]]></category>
		<guid isPermaLink="false">https://tissuepathology.com/?p=24687</guid>

					<description><![CDATA[<p>From the Proscia blog: Interoperability remains a major barrier to the scaled adoption of digital pathology. Signify Research took this away from their recent discussions with seven pathologists and leaders across academic and health system laboratories. It’s also a concern we hear often in our own conversations with laboratory leaders. The challenge lies in the technology ecosystem [&#8230;]</p>
The post <a href="https://tissuepathology.com/2026/09/18/proscia-freedom-to-grow-why-an-open-interoperable-platform-is-non-negotiable-for-digital-pathology/">Proscia: Freedom to Grow: Why an Open, Interoperable Platform Is Non-Negotiable for Digital Pathology</a> first appeared on <a href="https://tissuepathology.com">Tissuepathology.com</a>.]]></description>
		
		
		
			</item>
	</channel>
</rss>
